| CPC A61K 31/4439 (2013.01) [A61K 45/06 (2013.01); A61P 35/00 (2018.01)] | 9 Claims |

|
1. A pharmaceutical composition for treating pancreatic cancer, comprising a 3-ketoacyl CoA thiolase (ACAA) inhibitor and a carnitine acylcarnitine carrier (CAC) inhibitor,
wherein the ACAA inhibitor is trimetazidine, ranolazine, or a pharmaceutically acceptable salt thereof, and
wherein the CAC inhibitor is omeprazole, lansoprazole, pantoprazole, or a pharmaceutically acceptable salt thereof.
|